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Strengths and limitations of this study
 ► This is one of very limited studies analysing potential 
driving forces of an increase trend in the number of 
reported gonorrhoea cases between 2014 and 2017 
in China.
 ► Our study examined the multiple aspects of the 
gonorrhoea epidemic by analysing data from three 
different sources.
 ► The number of reported gonorrhoea cases might be 
underestimated based on a large number of private 
clinics that do not report gonorrhoea cases in China.
 ► This study was conducted in Guangdong, one of the 
most economically developed provinces in China; 
therefore, generalisability is a limitation of this study.
AbStrACt
Objectives An increased trend in the number of reported 
gonorrhoea cases has been observed between 2014 and 
2017 in China. This study aims to describe the reported 
epidemic of gonorrhoea and potential driving forces in 
Guangdong Province, China.
Design A review of surveillance data.
Participants Three different sources of data from 
Guangdong Province were analysed: gonorrhoea 
cases reported to the Chinese sexually transmitted 
infections (STI) case report system (CRS); a clinic- based 
retrospective study conducted to collect information on 
annual gonorrhoea screening coverage and data from the 
Guangdong governmental sentinel surveillance network 
(SSN) to examine the gonorrhoea prevalence among males 
attending STI clinics.
Outcome measures Reported incidence of gonorrhoea, 
number of reported gonorrhoea cases, number of 
screening tests for gonorrhoea and gonorrhoea prevalence.
results The STI CRS data showed that the reported 
incidence of gonorrhoea has increased rapidly from 15.7 
cases per 100 000 population in 2014 to 27.3 cases 
per 100 000 in 2017 in Guangdong (p<0.001). Regions 
with a reported incidence of gonorrhoea cases of more 
than 10 cases per 100 000 expanded from 7 cities in 
2014 to 13 cities in 2017. The SSN data showed that the 
gonorrhoea prevalence among males attending STI clinics 
increased from 2.7% in 2015 to 3.6% in 2017 (p=0.14). 
The retrospective study showed that the increased rate 
of screening for gonorrhoea between 2014 and 2017 was 
35.0%, which was much lower than the increased rate of 
the number of reported gonorrhoea cases (123.3%).
Conclusions The number of gonococcal infections is 
rapidly rising in Guangdong, China. Expanded screening 
coverage, use of more sensitive diagnostics and increase 
of gonorrhoea prevalence are three potential contributors 
to the epidemic. Additional targeted intervention strategies 
are necessary in the future to control the epidemic.
IntrODuCtIOn
Gonorrhoea continues to be a major public 
health concern in many settings because of 
the high incidence and antimicrobial resis-
tance.1–3 The WHO estimated that in 2012, 
there were 78 million cases among adults aged 
15–49 years worldwide with a global incidence 
rate of 19 per 1000 females and 24 per 1000 
males.4 Gonorrhoea infection is a leading 
cause of infertility, pelvic inflammatory 
disease and ectopic pregnancy. Additionally, 
gonorrhoea is known to increase transmis-
sion and acquisition of HIV by inducing the 
production of cytokines, chemokines and 
defensins to modulate HIV infection and 
infectivity.1 5–7
The number of reported gonorrhoea cases 
gradually declined in China from 2000 to 
2013, based on the Chinese sexually trans-
mitted infections (STI) case report system 
(CRS).8 This official STI CRS is a vital refer-
ence for STI control policy making, although 
repeated or erroneous reporting cases exist. 
However, there has been a recent reversal of 
this trend with a nearly 30% increase, from 
7.2 cases per 100 000 in 2014 to 10.1 cases 
per 100 000 in 2017.9 An increasing trend 
was also observed in several other countries, 
including the USA,10 the UK,11 France,12 
Australia and Greenland.13 Multiple factors 
including greater screening coverage, use 
of more sensitive diagnostics and high levels 
of unsafe sexual behaviour among certain 
subpopulations were likely contributors.14–16 
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However, there has been limited analysis of this trend in 
China to confirm the increase and the driving forces to 
date, which is critical to informing the design of tailored 
intervention programme.
To address this gap, we conducted this study in Guang-
dong Province. We selected this province because of a 
high burden of gonorrhoea,9 and a strong case reporting 
system.17 In 2017, the total burden of gonorrhoea in China 
was 10.1 cases per 100 000 population with Guangdong 
province reporting 27.3 cases per 100 000 population.9 
Guangdong has consistently ranked among the top three 
provinces with a high incidence of reported gonorrhoea 
cases and ranking first on the number of newly reported 
gonorrhoea cases in China in the last decade.8 9 Addi-
tionally, Guangdong has the most complete and effective 
surveillance system for STI among all the provinces in 
China17 and is able to provide high- quality surveillance 
data.
This study aims to describe the reported epidemic of 
gonorrhoea in Guangdong, China, and potential driving 
forces of the increasing.
MethODS
To investigate the reasons for the increasing gonorrhoea 
epidemic in Guangdong Province, we analysed data from 
three sources. First, we examined data from 2004 to 2017 
from the Guangdong Provincial STI CRS to describe the 
gonorrhoea epidemic. Second, we conducted a clinic- 
based retrospective study to explore the role of expanding 
screening coverage on the increasing trend for gonor-
rhoea between 2014 and 2017. Third, we analysed the data 
from the Guangdong governmental sentinel surveillance 
network to determine whether gonorrhoea prevalence 
among males attending STI clinics increased between 
2014 and 2017. The detailed information for these three 
different data sources is described below (online supple-
mentary figure 1).
Guangdong provincial StI CrS
The STI CRS was initiated by the Chinese Center for 
Disease Control and Prevention in 1985, and aims to 
survey syphilis, gonorrhoea, Chlamydia trachomatis, Condy-
loma acuminata and genital herpes across the country. 
The Guangdong Provincial STI CRS comprises 3261 
governmental health facilities within the 21 munici-
palities of Guangdong Province. In all health facilities 
(which include STI clinics, designated dermatovenere-
ology centres, gynaecology and genitourinary clinics, 
maternity and children’s hospitals and other health-
care entities) covered by this system, newly diagnosed 
STI cases are required to be reported to the STI CRS 
by each facility. Doctors or their assistants complete a 
standardised STI reporting card with socio- demographic 
(identification number, date of birth, sex, marital status, 
address and occupation), clinical (diagnostic evidence, 
and the onset of symptoms, diagnosis and death) and 
epidemiological information (transmission route). As of 
2005, STI case- reporting transitioned from paper reports 
to electronic online submissions in China. According 
to national guidelines,18 gonorrhoea cases are defined 
by positive diagnostic tests of sputum smear, culture or 
nucleic acid; history of sexual risk and characteristic clin-
ical manifestations. We extracted data between 2004 and 
2017 from the Guangdong Provincial STI CRS in this 
study.
Clinic-based retrospective study
A clinic- based retrospective study was conducted to 
collect information from January 2014 to December 2017 
on annual gonorrhoea screening coverage, the propor-
tion of different types of gonorrhoea testing methods 
including smear, culture, PCR and immunofluorescence, 
and the proportion of gonorrhoea cases detected by the 
above four testing methods. We selected hospitals for this 
study according to the following procedures. First, we 
extracted data from the Guangdong provincial STI CRS 
on the number of reported gonorrhoea cases of each 
city in Guangdong from 2014 to 2017. The cities with a 
higher rate of increase in the number of reported gonor-
rhoea cases between 2014 and 2017 than that of Guang-
dong province as a whole were selected for this study. 
Finally, within each city, the hospitals with a higher rate 
of increase in reported gonorrhoea cases between 2014 
and 2017 than that of the city were then selected. A total 
of 10 cities (Shenzhen, Guangzhou, Foshan, Zhuhai, 
Zhongshan, Jiangmen, Dongguan, Huizhou, Jieyang and 
Meizhou) and 40 public hospitals were finally selected in 
the study. Trained interviewers contacted the hospitals 
and completed a questionnaire by transcribing all existing 
medical records with the assistance of staff members from 
Information section.
Guangdong governmental sentinel surveillance network
To increase the accuracy and reliability with which gonor-
rhoea incidence could be assessed, a governmental 
sentinel surveillance network comprising 10 STI clinics 
in 10 cities (Zhuhai, Dongguan, Foshan, Jiangmen, 
Qingyuan, Shaoguan, Jieyang, Shantou, Maoming and 
Zhaoqing) with a high burden of gonorrhoea was estab-
lished in 2015 (online supplementary figure 2). A serial 
cross- sectional survey was routinely conducted in these 
sites among males attending STI clinics aged at least 15 
years old from April to June of each year. A standardised 
survey protocol designed by the Guangdong Provincial 
Centre for STI Control was sent to these sites for data 
collection and management. A minimum sample size of 
200–250 participants was required for each site.16 After 
providing verbal informed consent, those who agreed 
to participate in the study were referred to a separate, 
quiet room to complete a questionnaire including demo-
graphic, behavioural and clinical information with the 
help of a research assistant. Urine samples were collected 
from all eligible participants for gonorrhoea testing by 
nucleic acid amplification tests.
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Figure 1 Reported incidence of gonorrhoea from 2004 to 2017 based on the sexually transmitted infections case report 
system.
Statistical analysis
Measures derived from the Guangdong provincial STI 
CRS data included: (1) the reported incidence of gonor-
rhoea which was calculated by dividing the number of 
newly diagnosed gonorrhoea cases by the total popula-
tion of Guangdong province in a specified year; (2) the 
average yearly rate of increase in incidence which was 
calculated as a geometric mean by the use of the following 
formula: (incidence at years n divided by incidence at 
years m) ˆ (1/[n−m])−1. Guangdong provincial popula-
tion data were obtained from the Guangdong Bureau of 
Statistics of China.19
Measures for the clinic- based retrospective study 
included: (1) the average yearly rate of increase in the 
number of screening tests for gonorrhoea (see above); 
(2) the increased rate of screening amount for gonor-
rhoea between 2014 and 2017 which was calculated by the 
following formula: ([screening amount during year 2017−
screening amount during year 2014]/screening amount 
during year 2014)*100% and (3) the rate of increase in 
the number of reported gonorrhoea cases between 2014 
and 2017 (see above).
We calculated gonorrhoea prevalence from the Guang-
dong governmental sentinel surveillance network data, 
which refers to the total number of gonorrhoea cases 
divided by the total population of Guangdong province 
in a specified year.
We used the χ2 trend test to assess trends over years. 
Multivariable logistic regression was applied to examine 
the factors associated with gonorrhoea infection among 
males attending STI clinics between 2015 and 2017.
All analyses were conducted using SAS V.9.4 statistical 
software .
Patient and public involvement
The participants were not involved in the development 
of the research question, outcome measures, design, 
recruitment and conduct of this study.
reSultS
Data from Guangdong provincial StI CrS
A total of 85 671 gonorrhoea cases were reported in 
Guangdong Province between 2014 and 2017. The male- 
to- female ratio of gonorrhoea cases decreased from 6.6 in 
2014 to 6.5 in 2017 (χ2=607.11, p<0.001). While incidence 
decreased from 2004 to 2014, the reported incidence of 
gonorrhoea grew rapidly with an average yearly increase 
of 20.2% from 15.7 cases per 100 000 in 2014 to 27.3 
cases per 100 000 in 2017 (χ2=4133.81, p<0.001), which is 
similar to the trend in reporting incidence of male gonor-
rhoea cases (figure 1). In 2014, only seven cities located 
in the Pearl River Delta (Shenzhen, Foshan, Zhuhai, 
Zhongshan, Guangzhou, Dongguan and Jiangmen) had 
a reported incidence of gonorrhoea over 10 cases per 
100 000. In 2017, this epidemic was extended to an addi-
tional city in the Pearl River Delta (Huizhou), as well as 
four cities in the northern Guangdong (Qingyuan, Yunfu, 
Shaoguan and Heyuan), and one city in the eastern 
region (Shantou) (online supplementary figure 3).
Data from a clinic-based retrospective study
The clinic- based retrospective study showed that the 
number of screening tests for gonorrhoea increased from 
155 747 in 2014 to 210 238 in 2017 (p<0.001), with an 
average yearly increase of 10.5%. Among the five different 
testing methods for gonorrhoea, the number of PCR 
tests grew most rapidly with an average yearly increase 
of 39.9% from 10 792 (6.9%) in 2014 to 29 543 (14.1%) 
in 2017 (p<0.001), followed by culture testing with an 
average yearly increase of 13.5% from 42 172 (27.1%) in 
2014 to 61 675 (29.3%) in 2017 (p<0.001). Overall, the 
smear test was the most frequently used among the five 
different testing methods between 2014 and 2017.
The proportion of gonorrhoea cases detected by PCR 
increased from 11.3% to 12.9% between 2014 and 2017 
(p=0.57). This was similar to the immunofluorescence 
test, which increased from 1.5% to 4.5% (p<0.001). By 
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Table 1 Screening amount and positive gonorrhoea cases detected in the 40 hospitals, 10 cities from 2014 to 2017, a 
retrospective study
Test method 2014 2015 2016 2017 χ2 (p)
Smear*
  No. of tests (%) 88 879 (57.1) 76 202 (44.4) 74 784 (40.8) 97 774 (46.5) 3607.0 (<0.001)
  No. of positive cases (%) 2389 (48.0) 2546 (46.1) 3185 (42.4) 5005 (44.6) 824.2 (<0.001)
Culture*
  No. of tests (%) 42 172 (27.1) 67 137 (39.2) 72 031 (39.3) 61 675 (29.3) 22.5 (<0.001)
  No. of positive cases (%) 1948 (39.2) 2339 (42.3) 3262 (43.5) 4267 (38.0) 470.5 (<0.001)
PCR*
  No. of tests (%) 10 792 (6.9) 12 568 (7.3) 18 235 (9.9) 29 543 (14.1) 6203.5 (<0.001)
  No. of positive cases (%) 564 (11.3) 573 (10.4) 818 (10.9) 1445 (12.9) 0.3 (0.57)
Immunofluorescence*
  No. of tests (%) 13 904 (8.9) 15 549 (9.1) 18 384 (10.0) 21 246 (10.1) 270.2 (<0.001)
  No. of positive cases (%) 74 (1.5) 70 (1.3) 239 (3.2) 503 (4.5) 299.2 (<0.001)
Total*
  No. of tests (%, increased 
rate compared with 2014)
155 747 171 456 (10.1) 183 434 (17.8) 210 238 (35.0) 4525.4 (<0.001)
  No. of positive cases 4975 5528 7504 11 220 1318.1 (<0.001)
No. of reported cases (%, 
increased rate compared with 
2014)†
3600 3910 (8.6) 5627 (56.3) 8040 (123.3) 4133.8 (<0.001)
*These data for the 10 cities were obtained from the retrospective study.
†These data for the 10 cities were from STI CRS.
Figure 2 The yearly increased rate of screening coverage from the retrospective study and the number of reported cases from 
the sexually transmitted infections case report system based on 2014 in the 40 hospitals, 10 cities.
contrast, the proportion of gonorrhoea cases detected by 
the smear declined from 48.0% in 2014 to 44.6% in 2017 
(p<0.001), and by the culture declined from 39.2% in 
2014 to 38.0% in 2017 (p<0.001).
The rate of increase in the number of screening tests 
for gonorrhoea during the period from 2014 to 2017 was 
35.0%, which was much lower than the increased rate 
of the number of reported gonorrhoea cases (123.3%) 
during that time period (table 1 and figure 2).
Data from the Guangdong governmental sentinel surveillance 
network
Under the sentinel surveillance network programme, a 
total of 5440 participants were recruited, interviewed and 
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Table 2 Sexual risk behaviour among male attending sexually transmitted infections (STI) clinics between 2015 and 2017
2015 (n=1749) 2016 (n=1718) 2017 (n=1973)
χ2 (p)N % N % N %
Age 1.31 (0.25)
  11–20 99 5.7 50 2.9 85 4.3   
  21–30 453 25.9 406 23.6 495 25.1   
  31–40 444 25.4 431 25.1 543 27.5   
  41–50 392 22.4 442 25.7 417 21.1   
  51–60 195 11.1 215 12.5 231 11.7   
  >60 166 9.5 174 10.1 202 10.2   
Marital status 1.10 (0.29)
  Never married 386 22.1 405 23.6 405 20.5   
  Married/engaged 1332 76.1 1266 73.7 1534 77.8   
  Separated/divorced/
widowed
31 1.8 47 2.7 34 1.7   
Residency 21.3 (<0.001)
  Guangdong 1614 92.3 1482 86.3 1723 87.3   
  Out of Guangdong 135 7.7 236 13.7 250 12.7   
Had sex with female sex workers in the past 3 months 13.99 (0.002)
  Yes 432 26.2 512 30.9 633 32.1   
  No 1214 73.8 1147 69.1 1336 67.9   
Had sex with casual partners in the past 3 months 24.86 (<0.001)
  Yes 288 17.5 460 27.3 490 24.9   
  No 1357 82.5 1223 72.7 1478 75.1   
Recreational drug use 3.13 (0.08)
  Yes 9 0.5 3 0.2 4 0.2   
  No 1684 99.5 1702 99.8 1969 99.8   
Had anal intercourse with male partners 1.43 (0.23)
  Yes 52 3.1 47 2.8 48 2.4   
  No 1633 96.9 1657 97.2 1920 97.6   
Gonorrhoea 2.18 (0.14)
  Yes 48 2.7 59 3.5 70 3.6   
  No 1701 97.3 1640 96.5 1863 96.4   
Syphilis 1.05 (0.31)
  Yes 60 3.5 54 3.9 73 4.1   
  No 1677 96.5 1326 96.1 1699 95.9   
Chlamydia 1.24 (0.27)
  Yes 106 6.1 147 8.7 137 7.1   
  No 1641 93.9 1552 91.3 1796 92.9   
tested between 2015 and 2017. The gonorrhoea preva-
lence among males attending STI clinics increased with 
a yearly average of 14.94%, from 2.7% in 2015 to 3.6% in 
2017, although this increase was not significant (p=0.14). 
The proportion of male STI clinic attendees reporting 
having sex with female sex workers in the past 3 months 
grew significantly from 26.2% in 2015 to 32.1% in 2017 
(p=0.002). The same trend was also observed for the 
proportion of participants having sex with casual partners 
in the past 3 months from 17.5% in 2015 to 24.9% in 2017 
(p<0.001) (table 2).
In the multivariable model adjusted for age, marital 
status and residency, two factors were positively associ-
ated with gonorrhoea infection: having sex with female 
sex workers in the past 3 months (aOR: 2.55, 95% CI: 
1.89 to 3.45) and having sex with casual partners in 
the past 3 months (aOR: 1.49, 95% CI: 1.08 to 2.07) 
(table 3).
Tropical M
edicine. Protected by copyright.
 o
n
 N
ovem
ber 25, 2019 at London School of Hygiene and
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-031578 on 10 November 2019. Downloaded from 
6 Wang C, et al. BMJ Open 2019;9:e031578. doi:10.1136/bmjopen-2019-031578
Open access 
Table 3 Factors associated with gonorrhoea infection among males attending clinics between 2015 and 2017
Characteristics n (%)
Crude model Adjusted model†
OR (95% CI) OR (95% CI)
Had sex with female sex workers in the past 3 months
  Yes 1585 (30.2) 2.59 (1.92 to 3.50)* 2.55 (1.89 to 3.45)*
  No 3661 (69.8) Ref. Ref.
Had sex with casual partners in the past 3 months
  Yes 1216 (23.2) 1.59 (1.16 to 2.21)* 1.49 (1.08 to 2.07)*
  No 4022 (76.8) Ref. Ref.
Recreational drug use
  Yes 16 (0.3) 1.94 (0.26 to 14.76) 1.73 (0.23 to 13.26)
  No 5296 (99.7) Ref. Ref.
Had anal intercourse with male partners   
  Yes 147 (2.8) 1.24 (0.46 to 3.39) 1.44 (0.52 to 3.98)
  No 5151 (97.2) Ref. Ref.
*P<0.01.
†Adjusted model was adjusted for age (continuous), marital status and residency.
DISCuSSIOn
A rapid increase in the number of reported gonorrhoea 
cases has been observed since 2014 in China. This study 
applied multiple sources of surveillance data from Guang-
dong province to identify the reasons. Our data suggest 
that expanded screening coverage, use of more sensitive 
diagnostics and increase in gonorrhoea prevalence are 
three potential contributors to the epidemic. Findings 
from this study provide insights for the design of tailored 
gonorrhoea intervention programme in China.
Our study found that the reported incidence of gonor-
rhoea in Guangdong has been increasing since 2014, and 
the number of cities with a reporting incidence of gonor-
rhoea more than 10 cases per 100 000 expended from 7 
in 2014 to 13 in 2017 across Guangdong Province based 
on the provincial STI CRS. This increasing epidemic was 
similar to the epidemic across China, as well as that of 
many other countries, such as an 18.5% rise between 
2015 and 2016 in the USA,10 and a 22% rise between 
2017 and 2016 in the UK.11 Data from the Guangdong 
governmental sentinel surveillance network echoed this 
increasing trend among males attending STI clinics from 
2015 to 2017.
Results from the clinic- based retrospective study indi-
cated that gonorrhoea screening uptake levels have been 
rising with a yearly increase of 10.52% from 2014 to 
2017, especially with the increased use of PCR which is 
the most sensitive test for Neisseria gonorrhoea.20 Similar 
increases due to growing PCR use were also observed in 
several European countries.13 21 In China, this increase 
can be largely attributed to the Zero Mark- up Drug 
policy launched by the Chinese government in 200922 
and piloted in all county level public health facilities 
throughout Guangdong in 2013.23 The Zero Mark- up 
Drug policy mandates that all drugs must be sold with 
no markup from wholesale to retail price in all public 
health facilities.24 According to our previous qualitative 
study with physicians,25 this policy led to changes in diag-
nostic behaviours of doctors for gonorrhoea, such as 
increasing reliance on laboratory analysis over syndromic 
approaches.26 For example, prior to the implementation 
of this policy, physicians reported typically diagnosing 
male patients with gonococcal urethritis based on symp-
toms without conducting laboratory testing.27 After the 
policy was launched, physicians chose to provide labora-
tory testing to all male patients with urethral discharge for 
the diagnosis. This policy likely caused a rapid increase in 
the number of screening tests conducted for gonorrhoea 
in public health facilities.
While the screening coverage for gonorrhoea increased 
considerably between 2014 and 2017, we found that the 
rate of increase in gonorrhoea screening was much lower 
than the rate of increase in the number of reported 
gonorrhoea cases. Additionally, data from the govern-
mental sentinel surveillance network indicated that the 
proportion of males attending STI clinics engaging in 
risky sexual behaviour has also grown rapidly since 2015, 
which is an important factor relevant to the spread of 
STI.28 These results suggest that there was an increase 
in the population prevalence of gonorrhoea even if 
screening levels were not considered.
Our study has several limitations. First, only public 
health facilities are mandated to report STI in Guang-
dong Province. The number of reported gonorrhoea 
cases is likely underestimated based on a large number 
of private clinics that do not report gonorrhoea cases to 
the STI CRS.29 Second, the Guangdong sentinel surveil-
lance network only surveys males attending STI clinics, 
but not female attendees. Nevertheless, the trend of the 
incidence rate of male gonorrhoea cases can be used to 
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represent gonorrhoea cases overall in Guangdong. Third, 
there may have selection bias induced by non- response 
for the survey of sentinel surveillance network. Fourth, 
this study was conducted in Guangdong, one of the most 
economically developed provinces in China. We are 
uncertain whether the results can be generalised to other 
province in China. However, this study provides insights 
on contributing factors to the gonorrhoea epidemic and 
for gonorrhoea prevention at the provincial level.
COnCluSIOnS
In conclusion, the number of gonococcal infections is 
rapidly rising in Guangdong, China. We used data from 
multiple sources to explore reasons for this increase. 
Expended screening coverage, use of more sensitive diag-
nostics and increase of gonorrhoea prevalence are three 
potential contributors to the epidemic. Considering this 
increase in the number of gonorrhoea cases between 
2014 and 2017 coincided with decreasing susceptibility 
of N gonorrhoea to currently available antimicrobial 
drugs,30–34 prevention of gonorrhoea remains a major 
public health priority in China. More targeted interven-
tion strategies and efforts, such as early detection and 
screening strategies, partner management, development 
of new diagnostics and novel treatment options, should 
be paid more attention in the future.
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